Also known as: Zegalogue
Dasiglucagon is a synthetic peptide and a stable glucagon receptor agonist, primarily categorized under Endocrine & Reproductive Peptides. It is designed to mimic the action of natural glucagon, a hormone produced by the pancreas that plays a crucial role in glucose metabolism. Dasiglucagon is notable for its enhanced stability compared to traditional glucagon, making it a valuable tool in research and potential therapeutic applications.
Dasiglucagon functions by binding to the glucagon receptor, which is predominantly found in the liver. This interaction triggers a cascade of biochemical events that lead to increased glucose production and release from the liver into the bloodstream.
The peptide's stability allows it to maintain its efficacy over a longer duration, facilitating sustained activation of the glucagon receptor. This mechanism is particularly beneficial in conditions where rapid glucose mobilization is necessary, such as in hypoglycemic episodes.
Dasiglucagon is a significant peptide in the realm of endocrine research, particularly for its stable action as a glucagon receptor agonist. Its potential applications in managing diabetes and metabolic disorders highlight its relevance in ongoing scientific studies.
Last updated: Feb 25, 2026